These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10872718)

  • 1. Influenza virus genetics.
    Brown EG
    Biomed Pharmacother; 2000 May; 54(4):196-209. PubMed ID: 10872718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influenza, a special form of zoonosis].
    Rott R
    Berl Munch Tierarztl Wochenschr; 1997; 110(7-8):241-6. PubMed ID: 9324923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genome of influenza virus: organization, function, evolution].
    Kaverin NV
    Mol Biol (Mosk); 1980; 14(2):245-60. PubMed ID: 6991913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resistance in influenza viruses].
    Hungnes O; Dudman SG
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2601-6. PubMed ID: 19023375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human influenza a viral genes responsible for the restriction of its replication in duck intestine.
    Hatta M; Halfmann P; Wells K; Kawaoka Y
    Virology; 2002 Apr; 295(2):250-5. PubMed ID: 12033783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FluGenome: a web tool for genotyping influenza A virus.
    Lu G; Rowley T; Garten R; Donis RO
    Nucleic Acids Res; 2007 Jul; 35(Web Server issue):W275-9. PubMed ID: 17537820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies.
    Lackenby A; Democratis J; Siqueira MM; Zambon MC
    Antivir Ther; 2008; 13(6):809-20. PubMed ID: 18839782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-influenza drugs: the development of sialidase inhibitors.
    von Itzstein M; Thomson R
    Handb Exp Pharmacol; 2009; (189):111-54. PubMed ID: 19048199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells.
    Zhirnov OP; Vorobjeva IV; Saphonova OA; Poyarkov SV; Ovcharenko AV; Anhlan D; Malyshev NA
    J Clin Virol; 2009 Aug; 45(4):322-33. PubMed ID: 19546028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of drug-resistant influenza virus: population dynamical considerations.
    Regoes RR; Bonhoeffer S
    Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.
    Nijhuis M; van Maarseveen NM; Boucher CA
    Handb Exp Pharmacol; 2009; (189):299-320. PubMed ID: 19048205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biology of influenza viruses].
    Müller H
    Berl Munch Tierarztl Wochenschr; 2006; 119(3-4):91-100. PubMed ID: 16573199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses.
    Deyde VM; Okomo-Adhiambo M; Sheu TG; Wallis TR; Fry A; Dharan N; Klimov AI; Gubareva LV
    Antiviral Res; 2009 Jan; 81(1):16-24. PubMed ID: 18835410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host factors for replication and transcription of the influenza virus genome.
    Nagata K; Kawaguchi A; Naito T
    Rev Med Virol; 2008; 18(4):247-60. PubMed ID: 18383427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuraminidase inhibitors in therapy of influenza].
    Fladerer P; Wenisch C
    Acta Med Austriaca; 2000; 27(5):133-40. PubMed ID: 11261262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Various sides of influenza, part I--structure, replication, changeability of influenza viruses, clinical course of the disease, immunological response and laboratory diagnostics].
    Machała MK; Brydak LB
    Pol Merkur Lekarski; 2006 Sep; 21(123):270-6. PubMed ID: 17163190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors.
    Hurt AC; Ho HT; Barr I
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):795-805. PubMed ID: 17140356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral management of seasonal and pandemic influenza.
    Hayden FG; Pavia AT
    J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassortment and modification of hemagglutinin cleavage motif of avian/WSN influenza viruses generated by reverse genetics that correlate with attenuation.
    Lu JH; Long JX; Jia LJ; Liu YL; Shao WX; Zhang YM; Liu XF
    Acta Virol; 2006; 50(4):243-9. PubMed ID: 17177609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.